People who survive serious COVID-19 infections have long-lasting immune responses against the virus, according to a new study led by researchers at Massachusetts General Hospital (MGH).
Departments, Centers, & Programs:
Infectious Disease Associates
55 Fruit Street
Boston, MA 02114-2696
- MD, Johns Hopkins University School of Medicine
- Residency, Massachusetts General Hospital
American Board Certifications
- Internal Medicine, American Board of Internal Medicine
- Infectious Disease, American Board of Internal Medicine
Accepted Insurance Plans
My laboratory is focused on decreasing the global burden of mucosal and enteric infections of import affecting resource-limited and marginalized populations. I work in a multi center collaborative effort with investigators at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b),Partners In Health, and MGH-Harvard that has been focused on broadening our understanding of host-pathogen and immune responses during human infection by V.cholerae (the cause of cholera) and Salmonellaenterica serovar Typhi (the primary causes of enteric fever). Together, these organisms infect over 25 million individuals and kills over 300,000 individuals each year. Work in my laboratory has:
- included application of high-throughput proteomic and genomic platform technologies to identify immunogenic antigens for vaccine and diagnostic development and
- characterization of immune responses during human infection and vaccination with enteric infections
- Aug | 14 | 2018
Mass General researchers working to stop the spread of infectious disease are worried that proposed cuts to the NIH budget would eliminate a key resource for global health efforts.